Joint Filing Agreement
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G dated November 29, 2018 (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Syndax Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: November 29, 2018
683 CAPITAL MANAGEMENT, LLC | |||
By: | /s/ Xxx Xxxxxxx | ||
Name: | Xxx Xxxxxxx | ||
Title: | Authorized Person |
683 CAPITAL PARTNERS, LP | |||
By: | /s/ Xxx Xxxxxxx | ||
Name: | Xxx Xxxxxxx | ||
Title: | Authorized Person |
By: | /s/ Xxx Xxxxxxx | ||
Name: | Xxx Xxxxxxx |